Ascribing sell ratings to Lupin, Dr Reddy’s Laboratories, Zydus Lifesciences and Aurobindo Pharma, the brokerage said the US generic market has been declining and the pace could worsen.
RBI accepts 95% of bond buyback ahead of monetary policy review
Ahead of its bi-monthly monetary policy review, the Reserve Bank of India (RBI) accepted ₹23,855 crore worth of bids in its bond buyback, 95% of